Melanoma
Melanoma is a serious form of skin cancer that develops from melanocytes, the pigment-producing cells in the skin. It can appear as a new spot or a change in an existing mole and may spread to other parts of the body if not treated early.
High-Risk Melanoma: Neoadjuvant Pembrolizumab Study
We are studying the effects of pembrolizumab in patients with high-risk melanoma who have no signs of spread. The goal is to see if this treatment can improve outcomes before surgery.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have high risk primary melanoma (stages pT1b-4b)?
- Are you currently pregnant or breastfeeding?
- Have you had any systemic treatment for melanoma before?
- Do you have any serious medical conditions that could affect your participation?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZ Brussel
Medical Oncology
Ganshoren, Belgium
Sponsor: UZ Brussel
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.